Prozkoumejte nejčtenější články a videa na Campus Sanofi
Systematic review shows Beyfortus® reduces RSV hospitalizations by 83% and ICU admissions by 81% in real-world infant immunization programs.
Advanced Technologies & Treatments for Diabetes